Literature DB >> 30049441

The ferroptosis inducer erastin promotes proliferation and differentiation in human peripheral blood mononuclear cells.

Ding Wang1, Nan Xie2, Wanli Gao3, Rui Kang4, Daolin Tang5.   

Abstract

Peripheral blood mononuclear cells (PBMCs) contain multipotent progenitor cell populations and possess the potential to differentiate into various types of immune cells under both physiological and pathological conditions. Ferroptosis is a type of oxidative stress-associated cell death that is mainly mediated by lipid peroxidation. However, the function of ferroptosis in cell differentiation remains unknown. Here, we showed that the ferroptosis inducer erastin did not cause cell death in human PBMCs. In contrast, erastin-induced lipid peroxidation promoted human PBMC proliferation and differentiation into B cells and natural killer cells through inhibition of bone morphogenetic protein family expression. These findings uncover a new immune modulation function of erastin in promoting PBMC proliferation and differentiation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erastin; Ferroptosis; Immunity; Lipid peroxidation; PBMCs

Mesh:

Substances:

Year:  2018        PMID: 30049441      PMCID: PMC6179365          DOI: 10.1016/j.bbrc.2018.07.100

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7.

Authors:  Kanutte Huse; Maren Bakkebø; Morten P Oksvold; Lise Forfang; Vera I Hilden; Trond Stokke; Erlend B Smeland; June H Myklebust
Journal:  Eur J Immunol       Date:  2011-10-18       Impact factor: 5.532

Review 2.  ROS function in redox signaling and oxidative stress.

Authors:  Michael Schieber; Navdeep S Chandel
Journal:  Curr Biol       Date:  2014-05-19       Impact factor: 10.834

3.  Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.

Authors:  Xiaofang Sun; Xiaohua Niu; Ruochan Chen; Wenyin He; De Chen; Rui Kang; Daolin Tang
Journal:  Hepatology       Date:  2016-05-24       Impact factor: 17.425

4.  On the mechanism of action of phytohemagglutinin in cellular immunity.

Authors:  K Markley; S W Thornton; E Smallman
Journal:  Proc Soc Exp Biol Med       Date:  1972-01

5.  Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.

Authors:  Kui Shin Voo; Laura Bover; Megan Lundell Harline; Jinsheng Weng; Naoshi Sugimoto; Yong-Jun Liu
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  Regulation of ferroptotic cancer cell death by GPX4.

Authors:  Wan Seok Yang; Rohitha SriRamaratnam; Matthew E Welsch; Kenichi Shimada; Rachid Skouta; Vasanthi S Viswanathan; Jaime H Cheah; Paul A Clemons; Alykhan F Shamji; Clary B Clish; Lewis M Brown; Albert W Girotti; Virginia W Cornish; Stuart L Schreiber; Brent R Stockwell
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

Review 7.  Ferroptosis: process and function.

Authors:  Y Xie; W Hou; X Song; Y Yu; J Huang; X Sun; R Kang; D Tang
Journal:  Cell Death Differ       Date:  2016-01-22       Impact factor: 15.828

Review 8.  Autophagy and the integrated stress response.

Authors:  Guido Kroemer; Guillermo Mariño; Beth Levine
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

9.  BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1.

Authors:  Christian Kersten; Einar A Sivertsen; Marit E Hystad; Lise Forfang; Erlend B Smeland; June H Myklebust
Journal:  BMC Immunol       Date:  2005-05-09       Impact factor: 3.615

10.  Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling.

Authors:  Neil C Robson; Laura Hidalgo; Angeles Vicente; Alberto Varas; Tristan Mc Alpine; Heng Wei; Víctor G Martínez; Ana Entrena; Gustavo J Melen; Andrew S MacDonald; Alexander Phythian-Adams; Rosa Sacedón; Eugene Maraskovsky; Jonathan Cebon; Manuel Ramírez
Journal:  Cancer Res       Date:  2014-07-18       Impact factor: 12.701

View more
  17 in total

1.  Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.

Authors:  Elodie Pramil; Linda Herbi Bastian; Thomas Denèfle; Fariba Nemati; Malina Xiao; Eva Lardé; Karim Maloum; Damien Roos-Weil; Elise Chapiro; Magali Le Garff-Tavernier; Frédéric Davi; Didier Decaudin; Marika Sarfati; Florence Nguyen-Khac; Hélène Merle-Béral; Philippe Karoyan; Santos A Susin
Journal:  Blood Adv       Date:  2019-10-22

Review 2.  Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.

Authors:  Abhijit Chakraborty; Yang Li; Chen Zhang; Yanming Li; Scott A LeMaire; Ying H Shen
Journal:  J Mol Cell Cardiol       Date:  2021-09-28       Impact factor: 5.000

3.  Inhibition of ferroptosis promotes megakaryocyte differentiation and platelet production.

Authors:  Baoquan Song; Wenjing Miao; Qingya Cui; Bingyu Shi; Jian Zhang; Huiying Qiu; Leisheng Zhang; Yue Han
Journal:  J Cell Mol Med       Date:  2022-05-13       Impact factor: 5.295

4.  Ferroptosis in infection, inflammation, and immunity.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  J Exp Med       Date:  2021-05-12       Impact factor: 14.307

Review 5.  The Potential Role of Ferroptosis in Systemic Lupus Erythematosus.

Authors:  Qian Chen; Jie Wang; Mengmeng Xiang; Yilun Wang; Zhixiong Zhang; Jun Liang; Jinhua Xu
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

6.  Erastin Inhibits Septic Shock and Inflammatory Gene Expression via Suppression of the NF-κB Pathway.

Authors:  Byung Moo Oh; Seon-Jin Lee; Gyoung Lim Park; Yo Sep Hwang; Jeewon Lim; Eun Sun Park; Kyung Ho Lee; Bo Yeon Kim; Yong Tae Kwon; Hee Jun Cho; Hee Gu Lee
Journal:  J Clin Med       Date:  2019-12-14       Impact factor: 4.241

7.  Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma.

Authors:  Lei Zhu; Fugui Yang; Lingwei Wang; Lin Dong; Zhiyuan Huang; Guangxue Wang; Guohan Chen; Qinchuan Li
Journal:  Cancer Cell Int       Date:  2021-02-18       Impact factor: 5.722

Review 8.  Ferroptosis: molecular mechanisms and health implications.

Authors:  Daolin Tang; Xin Chen; Rui Kang; Guido Kroemer
Journal:  Cell Res       Date:  2020-12-02       Impact factor: 25.617

9.  Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction.

Authors:  Isabel Weigand; Jochen Schreiner; Florian Röhrig; Na Sun; Laura-Sophie Landwehr; Hanna Urlaub; Sabine Kendl; Katja Kiseljak-Vassiliades; Margaret E Wierman; José Pedro Friedmann Angeli; Axel Walch; Silviu Sbiera; Martin Fassnacht; Matthias Kroiss
Journal:  Cell Death Dis       Date:  2020-03-17       Impact factor: 8.469

10.  Abnormal Ferroptosis in Myelodysplastic Syndrome.

Authors:  Qi Lv; Haiyue Niu; Lanzhu Yue; Jiaxi Liu; Liyan Yang; Chunyan Liu; Huijuan Jiang; Shuwen Dong; Zonghong Shao; Limin Xing; Huaquan Wang
Journal:  Front Oncol       Date:  2020-09-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.